24849-48-7 Usage
Uses
Used in Pharmaceutical Industry:
4-HYDROXYBENZOYLACRYLIC ACID is used as a starting material for the synthesis of various pharmaceuticals due to its chemical reactivity and functional groups, which can be manipulated to create a range of medicinal compounds.
Used in Dye Industry:
In the dye industry, 4-HYDROXYBENZOYLACRYLIC ACID is utilized for the production of dyes, capitalizing on its ability to form colored compounds that have applications in textiles, inks, and other coloring processes.
Used in Polymer Manufacturing:
4-HYDROXYBENZOYLACRYLIC ACID is employed in the manufacturing of polymers, where its structural properties contribute to the development of materials with specific characteristics, such as improved strength or stability.
Used as a Chemical Intermediate in Organic Synthesis:
4-HYDROXYBENZOYLACRYLIC ACID serves as a valuable chemical intermediate in organic synthesis, facilitating the production of a wide array of organic compounds through its involvement in various chemical reactions.
Used in the Development of Therapeutic Agents:
Due to its antioxidant and anti-inflammatory properties, 4-HYDROXYBENZOYLACRYLIC ACID is of interest in the development of potential therapeutic agents, where it may contribute to the treatment or management of various conditions by modulating biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 24849-48-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,8,4 and 9 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 24849-48:
(7*2)+(6*4)+(5*8)+(4*4)+(3*9)+(2*4)+(1*8)=137
137 % 10 = 7
So 24849-48-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H8O4/c11-8-3-1-7(2-4-8)9(12)5-6-10(13)14/h1-6,11H,(H,13,14)/p-1/b6-5+
24849-48-7Relevant academic research and scientific papers
COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION
-
Page/Page column 53, (2021/06/11)
The invention relates to activated Michael acceptor (AMA) compounds that can undergo conjugation with biomolecules containing Michael donor moieties, thereby providing plasma-stable antibody-drug conjugates (ADCs). Pharmaceutical compositions of the ADCs are disclosed as well. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.
